Ubicom Holdings. Inc. · TSE:3937
Ubicom — FY2021 Q2 Earnings Presentation
22 slides from Ubicom's earnings presentation, November 2021
Slide 1: FY2021 Q2 Results Investor Briefing
FY2021 Q2 Consolidated Business Results FY2021 Q2 Results Investor Briefing Note : This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. © 2021
Slide 2: FY2021 Q2 Highlights
FY2021 Q2 Highlights The established high-profit model turned out to be effective, and we conducted strategic investment, increasing sales and profit. Profit hit a record high for the second quarter. Net Sales 2,268 million yen Ordinary Income 478 million yen ( 108.4% year-on-year) 126.7% year-on-ye
Slide 3: FY2021 Q2 (P/L)
FY2021 Q2 (P/L) In order to meet the strong demand for development and solutions expected in the second half, we enhanced strategic investment in leading-edge human resources. Ordinary income increased over 20% year on year. FY2020 FY2021 2 nd quarter 2nd quarter Year-on- % to % to Year [unit: milli
Slide 4: FY2021 Q2 Group's Strategic Investments Breakdown
FY2021 Q2 Group’s Strategic Investments Breakdown We boldly conducted investment for developing new pillar clients from whom an order amount of 100 million yen or larger is expected in the next term, and investment in education for medical engineers. Total strategic investments in 2Q 50 million yen
Slide 5: FY2021 Q2 Segment Overview: Global Business
FY2021 Q2 Segment Overview: Global Business We conducted strategic investment in human resources spending about 45 million yen for accelerating the increase of customers ahead of schedule, but secured an increase in profits from the previous fiscal year. FY2020 FY2021 Global Business Year-on- 2 nd q
Slide 6: Global Business: Advancement of Business Model
Global Business: Advancement of Business Model Generate pillar clients and high profitability through flexible offshore/onsite development Definition of pillar clients: Constant clients that are market leaders in each field with sales scale of several 100 million yen Establishment Offshore (our deve
Slide 7: Global Business: Mid-term Vision
Global Business: Mid-term Vision Promote acquisition of potential pillar clients and expand opportunities per customer ■Results in FY2021 2Q: acquired 4 new potential pillar clients Blockchain infrastructure, leading semiconductor 2Q manufacturer and electronic medical chart manufacturer Additional
Slide 8: Global Business: Initiatives to Realize the Mid-Term Vision 1
Global Business: Initiatives to Realize the Mid-Term Vision 1 Through the co-creation with alliance partners (small-sized technology-oriented architect ventures in Japan), Steadily advancing pillar client development and unit price raise Standard model Alliance model + M&A in the future Onsite Ubico
Slide 9: Global Business: Initiatives to Realize the Mid-Term Vision 2
Global Business: Initiatives to Realize the Mid-Term Vision 2 Promote business strategies targeted at the global market ■ Visions for the Global Business ① Off-shore × DX engineers (545,000 engineers short in 2030*) ② Provision of attractive career opportunities for young personnel in Asia ③ Targeti
Slide 10: FY2021 Q2 Segment Overview: Medical Business
FY2021 Q2 Segment Overview: Medical Business FY2020 FY2021 Medical Business Year-on- 2 nd quarter 2nd quarter Year (unit: million yen) Amount % to sales Amount % to sales Net Sales 675 100.0% 740 100.0% 109.6% Operating Income 337 49.9% 399 53.9% 118.4% • In the 2Q of FY2021, operating income grew a
Slide 11: Medical Business: Advancement of Business Model
Medical Business: Advancement of Business Model Expansion of highly profitable foundation with the subscription model Trend of Medical Business Performance Sales Composition Trend of Medical Business (unit: million yen) *recurring ratio: continuous sales ratio 1,435 1,301 53.9% 1,282 1,169 1,076 51.
Slide 12: Medical Business: Initiatives to Realize the Mid-Term Vision
Medical Business: Initiatives to Realize the Mid-Term Vision For solving the lack of manpower in the Japanese medical care field, we support the management of over 18,000* medical institutions. ■Vision and business environment of Medical Business ・Support for the reform of doctors’ workstyles with M
Slide 13: Medical Business: Improvement of Medical Institutions Management with Mighty Checker
Medical Business: Improvement of Medical Institutions Management with Mighty Checker ■Effect of reducing time for handling medical claims (medium-sized hospitals with about 200 beds assumed)* Correction of medical claims Reducing time Check by doctors by about 50% Reducing time by 20% further Visual
Slide 14: Insurance Knowledge Platform: Progress and Prospects
Insurance Knowledge Platform: Progress and Prospects Through marketing and provision of the prototype to several insurance companies, Taking steps towards the full-scale launch (start of recurring-revenue business) in the next term. ■ Progress and future plans Demonstrative experiments with respecti
Slide 15: Entire Group: Initiatives to Realize the Mid-Term Vision
Entire Group: Initiatives to Realize the Mid-Term Vision By developing medical engineers utilizing the base in the Philippines and enhancing the development of next-generation medical engines, we aim to grow our SaaS/recurring model. © 2021 Ubicom Holdings, Inc. 14
Slide 16: Global Strategies of Our Corporate Group
Global Strategies of Our Corporate Group We aim to form alliances with M&A partners and global partners in the medical field, etc. in very near future Global utilization of medical knowledge Utilization of young human resources in Asia Huge annual market size Creation of a recurring-revenue
Slide 17: The First Investment in the Medical Industry Contributing to SDGs
The First Investment in the Medical Industry Contributing to SDGs Invested in “illumigyn,” an Israeli medical start-up firm offering solutions for a remote gynecological platform Related SDGs Mid/long-term growth potential of the Femtech market Contribution to SDGs: Empowerment of women and enha
Slide 18: ESG: Towards Sustainable Development of Business, Society & Customer
ESG: Towards Sustainable Development of Business, Society & Customer ■Global Business ・Client DX (Business process reforms for clients through advanced technology support such as AI/Analytics/Automation/cloud) ・New Normal promotion (Offshore leveraging, non-face-to-face/non-contact/remote solution d
Slide 19: Promotion of the Leverage Strategy (the 2nd Growth Phase)
Promotion of the Leverage Strategy (the 2 nd Growth Phase) To maximize the synergy between the existing business and M&A, and promote the development of new recurring-revenue/SaaS model Themes of the ・Medical field ・Pillar clients: + 20 companies second growth phase ・Global market ・Sustainability Fo
Slide 20: Company Overview
Company Overview ■Company name: Ubicom Holdings, Inc. (TSE First Section: 3937) ■Strategic industry: Medical, Financial/Public, Automotive, Manufacturing/Robotics, etc. ■Our Business: Global Business is dedicated in solving IT resource shortage and promoting DX (Digital Transformation) in Japan, thr
Slide 21: Cautionary Note on Forward Looking Statements
Cautionary Note on Forward Looking Statements This material may contain forward looking statements and forecasts regarding the future outlook at the time of publication. They are subject to risks and uncertainties including, but not limited to, domestic and international economic conditions such
Slide 22: © 2021 Ubicom Holdings, Inc.
© 2021 Ubicom Holdings, Inc.